Skip to Main text

What's New RSS

The Nitto website is currently under system maintenance. Please try again later.
2015/Nov/20 Nitto’s ND-L02-s0201, RNAi Anti-Fibrosis Drug for the Treatment of Liver Fibrosis Granted FDA Fast Track Designation
2015/Nov/12 Nitto selected as one of the top 100 global companies in intellectual property and patents for the 5th consecutive year
2015/Nov/02 Nitto opens its Innovation Center in Shinagawa to create innovation with its customers

Back to Page Top